Detail
Article
Online article
FT
Medvik - BMC
  • Something wrong with this record ?

Magnetic resonance cholangiopancreatography (MRCP) using new negative per-oral contrast agent based on superparamagnetic iron oxide nanoparticles for extrahepatic biliary duct visualization in liver cirrhosis

K. Polakova, I. Mocikova, D. Purova, P. Tucek, P. Novak, K. Novotna, N. Izak, R. Bielik, R. Zboril, M. Herman

. 2016 ; 160 (4) : 512-517. [pub] 20160915

Language English Country Czech Republic

Document type Evaluation Study, Journal Article

Persistent link   https://www.medvik.cz/link/bmc17016690

BACKGROUND AND AIMS: Magnetic resonance cholangiopancreatography (MRCP) is often used for imaging of the biliary tree and is required by surgeons before liver transplantation. Advanced liver cirrhosis and ascites in patients however present diagnostic problems for MRCP. The aim of this study was to find out if the use of our negative per-oral contrast agent containing superparamagnetic iron oxide nanoparticles (SPIO) in MRCP is helpful for imaging of hepatobiliary tree in patients with liver cirrhosis. METHODS: Forty patients with liver cirrhosis were examined on a 1.5 T MR unit using standard MRCP protocol. Twenty patients (group A) underwent MRCP after administration of per-oral SPIO contrast agent 30 min before examination. In group B, twenty patients were examined without per-oral bowel preparation. Ascites was present in eleven patients from group A and in thirteen patients in group B. Four radiologists analyzed MR images for visibility and delineation of the biliary tree. χ(2) tests were used for comparison of the visibility of intrahepatic and extrahepatic biliary ducts in patients with and without ascites. RESULTS: Better extrahepatic biliary duct visualization and visibility of extraluminal pathologies in patients with ascites was proved after administration of SPIO contrast agent. No statistically significant difference between group A and B was found for visualization of extrahepatic biliary ducts in patients without ascites. Delineation of intrahepatic biliary ducts was independent on bowel preparation. CONCLUSIONS: Application of our negative per-oral SPIO contrast agent before MRCP improves the visualization of extrahepatic biliary ducts in patients with ascites which is helpful during the liver surgery, mainly in liver transplantation.

References provided by Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc17016690
003      
CZ-PrNML
005      
20241121123105.0
007      
ta
008      
170516s2016 xr ad f 000 0|eng||
009      
AR
024    7_
$a 10.5507/bp.2016.046 $2 doi
035    __
$a (PubMed)27641140
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a xr
100    1_
$a Poláková, Kateřina $u Regional Centre of Advanced Technologies and Materials, Departments of Physical Chemistry and Experimental Physics, Faculty of Science, Palacky University Olomouc, Czech Republic $7 xx0139779
245    10
$a Magnetic resonance cholangiopancreatography (MRCP) using new negative per-oral contrast agent based on superparamagnetic iron oxide nanoparticles for extrahepatic biliary duct visualization in liver cirrhosis / $c K. Polakova, I. Mocikova, D. Purova, P. Tucek, P. Novak, K. Novotna, N. Izak, R. Bielik, R. Zboril, M. Herman
520    9_
$a BACKGROUND AND AIMS: Magnetic resonance cholangiopancreatography (MRCP) is often used for imaging of the biliary tree and is required by surgeons before liver transplantation. Advanced liver cirrhosis and ascites in patients however present diagnostic problems for MRCP. The aim of this study was to find out if the use of our negative per-oral contrast agent containing superparamagnetic iron oxide nanoparticles (SPIO) in MRCP is helpful for imaging of hepatobiliary tree in patients with liver cirrhosis. METHODS: Forty patients with liver cirrhosis were examined on a 1.5 T MR unit using standard MRCP protocol. Twenty patients (group A) underwent MRCP after administration of per-oral SPIO contrast agent 30 min before examination. In group B, twenty patients were examined without per-oral bowel preparation. Ascites was present in eleven patients from group A and in thirteen patients in group B. Four radiologists analyzed MR images for visibility and delineation of the biliary tree. χ(2) tests were used for comparison of the visibility of intrahepatic and extrahepatic biliary ducts in patients with and without ascites. RESULTS: Better extrahepatic biliary duct visualization and visibility of extraluminal pathologies in patients with ascites was proved after administration of SPIO contrast agent. No statistically significant difference between group A and B was found for visualization of extrahepatic biliary ducts in patients without ascites. Delineation of intrahepatic biliary ducts was independent on bowel preparation. CONCLUSIONS: Application of our negative per-oral SPIO contrast agent before MRCP improves the visualization of extrahepatic biliary ducts in patients with ascites which is helpful during the liver surgery, mainly in liver transplantation.
650    _2
$a aplikace orální $7 D000284
650    _2
$a dospělí $7 D000328
650    _2
$a senioři $7 D000368
650    _2
$a senioři nad 80 let $7 D000369
650    _2
$a žlučové cesty extrahepatické $x patologie $7 D017734
650    _2
$a žlučové cesty intrahepatální $x patologie $7 D001653
650    _2
$a magnetická rezonanční cholangiopankreatografie $x metody $7 D049448
650    12
$a kontrastní látky $7 D003287
650    _2
$a ženské pohlaví $7 D005260
650    12
$a železité sloučeniny $7 D005290
650    _2
$a lidé $7 D006801
650    _2
$a jaterní cirhóza $x patologie $7 D008103
650    _2
$a mužské pohlaví $7 D008297
650    12
$a kovové nanočástice $7 D053768
650    _2
$a lidé středního věku $7 D008875
650    _2
$a mladý dospělý $7 D055815
655    _2
$a hodnotící studie $7 D023362
655    _2
$a časopisecké články $7 D016428
700    1_
$a Mocikova, Ingrid $u Medihope s.r.o., Mathonova 291/1, 796 04 Prostejov, Czech Republic; Department of Radiology, F.D.Roosevelt Faculty Hospital, Banska Bystrica, Slovak Republic
700    1_
$a Purova, Dana $u Department of Geoinformatics, Faculty of Science, Palacky University Olomouc, Czech Republic
700    1_
$a Tucek, Pavel $u Department of Geoinformatics, Faculty of Science, Palacky University Olomouc, Czech Republic
700    1_
$a Novak, Pavel $u Medihope s.r.o., Mathonova 291/1, 796 04 Prostejov, Czech Republic.
700    1_
$a Novák, Pavel, $d 1954- $u Department of Radiology, F.D.Roosevelt Faculty Hospital, Banska Bystrica, Slovak Republic. $7 xx0079052
700    1_
$a Izák, Nikola $u Department of Radiology, F.D.Roosevelt Faculty Hospital, Banska Bystrica, Slovak Republic. $7 xx0118839
700    1_
$a Bielik, Radoslav $u Department of Radiology, F.D.Roosevelt Faculty Hospital, Banska Bystrica, Slovak Republic. $7 xx0325889
700    1_
$a Zbořil, Radek, $u Regional Centre of Advanced Technologies and Materials, Departments of Physical Chemistry and Experimental Physics, Faculty of Science, Palacky University Olomouc, Czech Republic. $d 1973- $7 xx0140669
700    1_
$a Heřman, Miroslav, $d 1959- $u Department of Radiology, Faculty of Medicine and Dentistry, Palacky University Olomouc, Czech Republic. $7 jn20000400945
773    0_
$w MED00012606 $t Biomedical papers of the Medical Faculty of the University Palacký, Olomouc Czech Republic $x 1213-8118 $g Roč. 160, č. 4 (2016), s. 512-517
910    __
$a ABA008 $b A 1502 $c 958 $y 4 $z 0
990    __
$a 20170516 $b ABA008
991    __
$a 20241121123058 $b ABA008
999    __
$a ok $b bmc $g 1205830 $s 977499
BAS    __
$a 3
BAS    __
$a PreBMC
BMC    __
$a 2016 $b 160 $c 4 $d 512-517 $e 20160915 $i 1213-8118 $m Biomedical papers of the Medical Faculty of the University Palacký, Olomouc Czech Republic $n Biomed. Pap. Fac. Med. Palacký Univ. Olomouc Czech Repub. (Print) $x MED00012606
LZP    __
$b NLK118 $a Pubmed-20170516

Find record

Citation metrics

Archiving options